Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCDART-MC study of antiretroviral therapy effects on pregnancy and child outcomes in South African women with HIV
PACTR202504553455452Phase 0Not yet recruiting
- Sponsor
- South African Medical Research Council
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 0, open-label trial in human immunodeficiency virus infection (HIV) (2 arms), sponsored by South African Medical Research Council. Primary endpoints: Gestational hypertension incidence, Gestational diabetes incidence and 7 more. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202504553455452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202504553455452.